IMA to Organize Conference on “Multispecialities Cardio Reno Metabolic & HF in Women” Tomorrow
A day long “Multispecialities Cardio Reno Metabolic Conference & HF in Women" is being organized by Indian Medical Association (IMA),...
A day long “Multispecialities Cardio Reno Metabolic Conference & HF in Women" is being organized by Indian Medical Association (IMA),...
Detailed results from the DELIVER Phase III trial showed AstraZeneca’s dapagliflozin significantly reduced the composite of cardiovascular (CV) death or worsening...